This study is a prospective registry that aims to predict readmissions in patients with heart failure, using -omics, machine learning, patient reported outcomes, clinical data and other high-dimensional data sources.
Eligibility
Sex
ALL
Min age
18 Years
Max age
105 Years
Healthy volunteers
No
Inclusion Criteria:
* Any patient aged 18 years or older admitted to hospital or seen in the emergency department with heart failure defined clinically
* The diagnosis will be guided by the Framingham criteria for HF and/or BNP. A BNP \>400 will be defined as definite heart failure and BNP 100-400 classified as possible heart failure.
* Provides informed consent
Exclusion Criteria:
* Patients who cannot communicate due to dementia or severe cognitive deficits
* non-Ontario residents
* nursing home residents
* those who are not discharged home but are discharged to a skilled nursing facility (long-term care or chronic institution)
* those who are unable to communicate who do not have a proxy (e.g. spouse or close family member) to facilitate communication with the patient.
Primary outcome measure(s)
Cardiovascular readmission — 30 day Non-elective readmission to hospital for a cardiovascular cause
Heart failure readmission — 30 day Non-elective readmission to hospital for heart failure
Trial sites (1)
Facility
City
Region
Status
University Health Network
Toronto
Ontario
Recruiting
More Institute for Clinical Evaluative Sciences trials in Canada
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.